Qualigens Pharma Private Limited Simvastatin Export Data — India (DGFT 2022–2026)

Name: Qualigens Pharma Private Limited Simvastatin Export Records India — #11 Exporter, 27 Shipments, $1.4M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Simvastatin

India Pharmaceutical Trade Intelligence

$125.9M150 Suppliers84 CountriesHS 30049099

ExportsIndia → UNITED STATES29.0%India → HUNGARY21.3%

ImportsCANADA → India$8.8M MALTA → India$3.0M

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN HUNGARY

Qualigens Pharma Private Limited — Simvastatin Exporter #11 | $1.4M Trade Value | TransData Nexus | TransData Nexus

Qualigens Pharma Private Limited — Simvastatin Exporter Profile

Indian Pharmaceutical Exporter · #11 for Simvastatin · $1.4M export value · DGFT Verified

Qualigens Pharma Private Limited is the #11 Indian exporter of Simvastatin with $1.4M in export value and 27 verified shipments. Qualigens Pharma Private Limited holds a 1.1% market share in Simvastatin exports across 1 countries. The company exports 3 pharmaceutical products worth $8.2M across 3 therapeutic categories.

Qualigens Pharma Private Limited — Simvastatin Export Profile: Buyers & Destinations

Qualigens Pharma Private Limited Simvastatin export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Simvastatin?

Country	Value	Shipments	Share
UNITED STATES	$32.4M	647	41.2%
BELGIUM	$9.4M	403	12.0%
MALTA	$7.3M	473	9.3%
AUSTRALIA	$3.9M	168	5.0%

Who Are the Top Buyers of Simvastatin from India?

Buyer	Country	Value	Orders
YUSEN LOGISTICS BENELUX BELGIUM	BELGIUM	$8.9M	368
APL SWIFT SERVICES (MALTA) LTD.,	MALTA	$5.6M	295
MYLAN HUNGARY KFT,	HUNGARY	$1.9M	39
ORION CORPORATION,	FINLAND	$1.1M	36
FAWDON MANUFACTURING CENTRE ( SF )	UNITED KINGDOM	$986.5K	47
MYLAN HUNGARY KFT	HUNGARY	$750.0K	15
APOTEX PTY LIMITED	AUSTRALIA	$750.0K	15
AMB HK ENTERPRISES INC.	PHILIPPINES	$700.0K	14
XXRTHXXAR XXALTXXAREX	UNITED STATES	$600.0K	12
XXROBXXDO XXARMXXUSAXXNC	UNITED STATES	$350.0K	7

India's Simvastatin is purchased by 421 buyers worldwide. The top buyer is YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), followed by APL SWIFT SERVICES (MALTA) LTD., and MYLAN HUNGARY KFT,.

How Does Qualigens Pharma Private Limited Compare to Nearest Simvastatin Exporters?

Exporters ranked immediately above and below #11 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
13	ALKEM LABORATORIES LIMITED	$1.9M	98	4	$19.3K
14	CIPLA LIMITED	$1.6M	131	4	$12.3K
11	QUALIGENS PHARMA PRIVATE LIMITED ★	$1.4M	27	1	$50.0K
15	WATSON PHARMA PRIVATE LIMITED	$1.1M	33	3	$32.7K
8	FREDUN PHARMACEUTICALS LTD	$950.0K	19	1	$50.0K

Qualigens Pharma Private Limited ranks #11 among 150 Indian Simvastatin exporters. Average shipment value of $50.0K compared to the market average of $538.9K. The closest competitors by value are ALKEM LABORATORIES LIMITED and CIPLA LIMITED.

Which Indian Ports Ship Simvastatin Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	422	10.9%
SAHAR AIR CARGO ACC (INBOM4)	301	7.8%
SAHAR AIR	240	6.2%
JNPT/ NHAVA SHEVA SEA	228	5.9%
DELHI AIR	216	5.6%
DELHI AIR CARGO ACC (INDEL4)	202	5.2%
VIZAG SEA	177	4.6%
MUNDRA SEA	150	3.9%

Geopolitical & Trade Policy Impact on Qualigens Pharma Private Limited's Simvastatin Exports

The ongoing Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to alter trade routes. This has resulted in extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes. (livemint.com) For Qualigens, these disruptions translate to higher shipping costs and potential delays in fulfilling European orders, affecting customer satisfaction and profitability.

In the United States, the imposition of tariffs on pharmaceutical imports poses a challenge for Indian exporters. While generics remain exempt from the 100% tariffs, any future expansion of the tariff regime to generics and biosimilars could disproportionately impact India, which supplies almost 40% of US generics. (orfonline.org) This situation necessitates strategic planning for Qualigens to maintain its competitive edge in the U.S. market.

Conversely, the India–European Union Free Trade Agreement, concluded on January 27, 2026, offers a favorable development. The agreement eliminates tariffs on most European pharmaceutical exports to India and vice versa, potentially enhancing Qualigens' access to the European market. (en.wikipedia.org) This could offset some of the adverse effects of other geopolitical challenges.

Qualigens Pharma Private Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practices (EU GMP) set stringent guidelines to ensure product safety and efficacy. Any lapses can lead to import bans or recalls, severely impacting a company's reputation and financial standing.

For Qualigens, maintaining compliance is critical, especially given its focused product portfolio. Investing in robust quality control systems and staying abreast of evolving regulations will be essential to sustain and grow its export business. Additionally, the company must be prepared to adapt to new regulatory frameworks that may arise from geopolitical developments, such as the EU's falsified medicines directive compliance requirements.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Simvastatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Qualigens Pharma Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 84+ countries, 421+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Simvastatin

Simvastatin

Qualigens Pharma Private Limited — Simvastatin Exporter Profile

Qualigens Pharma Private Limited — Simvastatin Export Profile: Buyers & Destinations

Where Does India Export Simvastatin?

Who Are the Top Buyers of Simvastatin from India?

What Is India's Total Simvastatin Export Value and How Much Does Qualigens Pharma Private Limited Contribute?

What Is the Average Shipment Value for Qualigens Pharma Private Limited's Simvastatin Exports?

How Does Qualigens Pharma Private Limited Compare to Other Indian Simvastatin Exporters?

Regulatory Requirements: Exporting Simvastatin to Key Markets

United States — FDA

Australia — TGA

How Does Qualigens Pharma Private Limited Compare to Nearest Simvastatin Exporters?

Which Indian Ports Ship Simvastatin Exports?

Geopolitical & Trade Policy Impact on Qualigens Pharma Private Limited's Simvastatin Exports

Qualigens Pharma Private Limited — Regulatory Compliance & Quality Standards

About Qualigens Pharma Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Simvastatin Export Data from Qualigens Pharma Private Limited

Simvastatin Stats

Company Overview

Top Products by Qualigens Pharma Private Limited

Related Analysis

Need Detailed Export Data?

Data Source